| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Service of Bone Diseases (World Health Organization Collaborating Centre for Osteoporosis Prevention), Department of Rehabilitation and Geriatrics (T.C., J.-P.B., S.F., R.R.) and Service of Nuclear Medicine, Department of Radiology (D.H.), University Hospitals of Geneva, CH-1211 Geneva 14, Switzerland
Address all correspondence and requests for reprints to: Thierry Chevalley, M.D., Service of Bone Diseases, Department of Rehabilitation and Geriatrics, University Hospitals of Geneva, CH-1211 Geneva 14, Switzerland. E-mail: thierry.chevalley{at}hcuge.ch.
Background: Calcium supplementation during childhood and adolescence is considered an early means of preventing osteoporosis in adults. Prepuberty is an opportune time for detecting the benefits of calcium in girls.
Objective: The objective was to assess whether calcium supplementation increases bone mass gain in prepubertal boys in a skeletal site-specific manner.
Methods: In a 12-month double-blind, placebo-controlled trial with 1-yr follow-up, 235 healthy prepubertal boys aged 7.4 ± 0.4 yr (mean ± SD) were randomized to receive two food products providing 850 mg/d calcium (calcium supplement group, n = 116) or an isocaloric placebo (n = 119). Areal bone mineral density (aBMD) was determined by dual-energy x-ray absorptiometry at radius (two sites), hip (two sites), femoral diaphysis (FDia), and L2L4 vertebrae.
Results: At 12 months, aBMD gain was greater at the FDia and at the mean of the five appendicular skeletal sites in the calcium supplement group in both intention-to-treat analysis [76 ± 32 vs. 64 ± 33 mg/cm2·yr; difference, 12.0 (95% confidence interval, CI, 3.620.3), P = 0.006; and 33 ± 16 vs. 28 ± 16 mg/cm2·yr; difference, 5.1 (95% CI, 0.99.2); P = 0.018, respectively] and active treatment analysis [81 ± 32 vs. 64 ± 31 mg/cm2·yr; difference, 17.2 (95% CI, 7.926.5); n = 174, P < 0.001; and 35 ± 16 vs. 28 ± 14 mg/cm2·yr; difference, 7.5 (95% CI, 2.912.2); P = 0.002]. There was no beneficial effect of calcium on lumbar spine. The calcium effect was still detectable by ANOVA repeated measures analysis at the FDia (P = 0.004) and at the mean of the five appendicular skeletal sites (P = 0.002) 1 yr after the end of intervention (active treatment analysis). There was no change in bone size.
Conclusion: In prepubertal boys, calcium-enriched foods increased aBMD at several appendicular skeleton sites, but not at the lumbar spine, and this without any bone size change. This effect was maintained 1 yr after treatment discontinuation.
This article has been cited by other articles:
![]() |
L. Richert, T. Chevalley, D. Manen, J.-P. Bonjour, R. Rizzoli, and S. Ferrari Bone Mass in Prepubertal Boys Is Associated with a Gln223Arg Amino Acid Substitution in the Leptin Receptor J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4380 - 4386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gugatschka, H. Dobnig, A. Fahrleitner-Pammer, P. Pietschmann, S. Kudlacek, A. Strele, and B. Obermayer-Pietsch Molecularly-defined lactose malabsorption, milk consumption and anthropometric differences in adult males QJM, December 1, 2005; 98(12): 857 - 863. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |